| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 199,100 | 218,256 | 212,319 | 250,632 | | Cost of Revenue | (257,744) | 257,744 |
-
| 156,447 | | | Gross Profit | 456,844 | (39,488) | 212,319 | 94,185 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 421,437 | (88,482) | 176,226 | 48,590 | | Non Recurring | 6,586 |
-
|
-
| 7,233 | | Others | 29,482 | 28,647 | 28,071 | 29,946 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (661) | 20,347 | 8,022 | 8,416 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 25 | 15,877 | 20,382 | 23,467 | | Earnings Before Interest And Taxes | 2,667 | 36,341 | 28,404 | 31,430 | | Interest Expense | 18,676 | 18,229 | 18,600 | 20,024 | | Income Before Tax | (16,009) | 18,112 | 9,804 | 11,406 | | Income Tax Expense | (2,954) | 7,983 | 6,286 | 1,991 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (13,055) | 10,129 | 3,518 | 9,415 | | | Non-recurring Events | | Discontinued Operations | 154 | (78) | (91) | (1,012) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (12,901) | 10,051 | 3,427 | 8,403 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($12,901) | $10,051 | $3,427 | $8,403 |
|
0.63% Nasdaq 
0.03%
Income Statement
